AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

In an editorial, J. Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO ...

The AstraZeneca PLC ADR AZN advanced 2.86% to $70.94 Wednesday, on what proved to be an all-around favorable trading session ...

This summary covers recent health news, including stable pig prices in Germany, investor focus on AstraZeneca's China probe, ...

In recognition of World Cancer Day 2025, AstraZeneca reaffirms its commitment to advancing early detection, innovative ...

Trials in China usually recruit patients faster than in the west because of the country’s large pool of people who have not yet taken drugs for their condition and who are keen to participate in ...

One of the newest engineering marvels to come out of Kendall Square will be buried up to 105 feet underground where no one ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

Harvey Jones called on artificial intelligence to help him decide where to invest this year's Stocks and Shares ISA allowance ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

SINGAPORE attracted some S$13.5 billion in fixed asset investment (FAI) commitments in 2024, over half of which were in ...

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.